Horizon Therapeutics plc to Participate in Upcoming Investor Conferences

Horizon Therapeutics plc to Participate in Upcoming Investor Conferences


DUBLIN--(BUSINESS WIRE)--Nov. 13, 2019-- Horizon Therapeutics plc (Nasdaq: HZNP) today announced that the Company will participate in the following upcoming conferences:

Stifel 2019 Healthcare Conference

  • Date: Tuesday, Nov. 19, 2019
  • Presentation Time: 9:45 a.m. EST
  • Location: New York

Jefferies 2019 London Healthcare Conference

  • Date: Wednesday, Nov. 20, 2019
  • Presentation Time: 8:00 a.m. GMT
  • Location: London

Piper Jaffray 31st Annual Healthcare Conference

  • Date: Tuesday, Dec. 3, 2019
  • Presentation Time: 12:00 p.m. EST
  • Location: New York

The conference presentations will be webcast live and may be accessed by visiting Horizon's website at http://ir.horizontherapeutics.com. A replay of the webcasts will be available for the events.

About Horizon

Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives. For more information on how we go to incredible lengths to impact lives, please visit www.horizontherapeutics.com, follow us @HorizonNews on Twitter, like us on Facebook or explore career opportunities on LinkedIn.

Source: Horizon Therapeutics plc

Tina Ventura
Senior Vice President,
Investor Relations

Ruth Venning
Executive Director,
Investor Relations

U.S. Media:
Geoff Curtis
Executive Vice President,
Corporate Affairs & Chief Communications Officer

Ireland Media:
Ray Gordon
Gordon MRM